Loading...
Loading chart...




The current price of GENB is 13.09 USD — it has increased 3.48
Wall Street analysts forecast GENB stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for GENB is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
Generate Biomedicines, Inc. revenue for the last quarter amounts to NaN USD, decreased
Generate Biomedicines, Inc.. EPS for the last quarter amounts to USD, decreased
Generate Biomedicines, Inc. (GENB) has 0 emplpoyees as of March 02 2026.
Today GENB has the market capitalization of 1.61B USD.